Abstract:The Metarhizium fungal species are considered the prolific producers of bioactive secondary metabolites with a variety of chemical structures. In this study, the biosynthetic potential of marine-derived fungus Metarhizium sp. P2100 to produce bioactive alkaloids was explored by using the one strain many compounds (OSMAC) strategy. From the rice solid medium (mixed with glucose peptone and yeast broth (GPY)), wheat solid medium (mixed with Czapek) and GPY liquid medium, one rare N-butenone spiroquinazoline alkaloid, N-butenonelapatin A (1), together with nine known compounds (2–10), were isolated and identified. Their structures were elucidated by analysis of the comprehensive spectroscopic data, including 1D and 2D NMR and HRESIMS, and the absolute configuration of 1 was determined by a single-crystal X-ray crystallographic experiment. N-butenonelapatin A (1) represents the first example of N-butenone spiroquinazoline with a rare α, β-unsaturated ketone side chain in the family of spiroquinazoline alkaloids. Compound 4 displayed antibacterial activity against Vibrio vulnificus MCCC E1758 with a minimum inhibitory concentration (MIC) value of 6.25 µg/mL. Compound 7 exhibited antibacterial activities against three aquatic pathogenic bacteria, including V. vulnificus MCCC E1758, V. rotiferianus MCCC E385 and V. campbellii MCCC E333 with the MIC values of 12.5, 12.5 and 6.25 μg/mL, respectively. Compounds 3 and 6 demonstrated anti-inflammatory activity against NO production induced by lipopolysaccharide (LPS) with the IC50 values of 37.08 and 37.48 μM, respectively. In addition, compound 1 showed weak inhibitory activity against the proliferation of tumor cell lines A-375 and HCT 116. These findings further demonstrated that fungi of the Metarhizium species harbor great potentials in the synthesis of a variety of bioactive alkaloids.

Study on Bioactive Alkaloids Ingredient Produced by Marine Actinomyces N331

Study on Bioactive Antibacterial Activty of Anthraquinones Produced from Marine Actinomyces WBF16

Preliminary Research of Bioactive Metabolite Produced by Marine Actinomyces M326

Preliminary Study on the Antibiotic Active Metabolites Produced by Marine Actinomyces M324

Preliminary Study of Cytotoxic Metabolite Produced by Marine Actinomycete M313

Bioactive Alkaloids from Sponge-Derived Actinomyces Sh6004

Antibacterial activity and active ingredients of Streptomyces albus C-411

Fermentation Conditions and Characteristics of Antibiotic Active Substance from Marine Actinomycete M324

Cytotoxic and Antifungal Staurosporine Derivatives from Marine-Derived Actinomycete Streptomyces Sp. ZS-A121

Cytotoxic and antimicrobial activities of secondary metabolites isolated from the deep-sea-derived Actinoalloteichus cyanogriseus 12A22

Preliminary Study on Antitumor Activity of Culture Broths from a Marine Actinomycete

The Cytotoxic Constituents from Marine-Derived Streptomyces 3320 #

Bioactive Alkaloids from the Marine-Derived Fungus Metarhizium Sp. P2100

Antibacterial Activity of Broth of Marine Actinomycete WB-F5 and Isolation and Identification of Its Anti-bacterial Substances

Three Novel Cyclic Hexapeptides from Streptomyces Alboflavus 313 and Their Antibacterial Activity

Study on Chemical Constituents from Marine-derived Penicillium sp.

Bioactive metabolite and taxonomic identification of actinomycete strain HCCB01128

New bioactive compounds from the marine-derived actinomycete Nocardiopsis lucentensis sp. ASMR2

Secondary metabolites and their biological activities of two actinomycetes Streptomyces coelico flavus and Nocardiopsis dassonvillei associated with ascidians Styela clava and Botryllus schlosseri

Purification and structure elucidation of antifungal bioactive metabolites from marine actinomycete Y12-26

Monascuslactams A–D, Cytotoxic Γ-Lactams from Marine Fungus Monascus Albidus BB3